NeuroPace Management
Management criteria checks 2/4
NeuroPace's CEO is Joel Becker, appointed in Jul 2023, has a tenure of 1.83 years. total yearly compensation is $3.02M, comprised of 17.5% salary and 82.5% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth $152.28K. The average tenure of the management team and the board of directors is 1.5 years and 3.8 years respectively.
Key information
Joel Becker
Chief executive officer
US$3.0m
Total compensation
| CEO salary percentage | 17.48% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1.5yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
NeuroPace, Inc. (NASDAQ:NPCE) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
May 13
Expanding Level 4 Epilepsy Centers Will Unlock Future Potential
Expanding presence in epilepsy centers and Project CARE may significantly boost revenue by increasing market penetration and service delivery.NeuroPace, Inc. (NASDAQ:NPCE) Annual Results: Here's What Analysts Are Forecasting For This Year
Mar 07NeuroPace, Inc. (NASDAQ:NPCE) Looks Just Right With A 26% Price Jump
Jan 24After Leaping 90% NeuroPace, Inc. (NASDAQ:NPCE) Shares Are Not Flying Under The Radar
Dec 04Here's What Analysts Are Forecasting For NeuroPace, Inc. (NASDAQ:NPCE) After Its Third-Quarter Results
Nov 14Does NeuroPace (NASDAQ:NPCE) Have A Healthy Balance Sheet?
Nov 07NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch
Aug 03Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$25m |
| Dec 31 2024 | US$3m | US$529k | -US$27m |
| Sep 30 2024 | n/a | n/a | -US$28m |
| Jun 30 2024 | n/a | n/a | -US$30m |
| Mar 31 2024 | n/a | n/a | -US$32m |
| Dec 31 2023 | US$2m | US$248k | -US$33m |
Compensation vs Market: Joel's total compensation ($USD3.02M) is about average for companies of similar size in the US market ($USD2.71M).
Compensation vs Earnings: Joel's compensation has increased whilst the company is unprofitable.
CEO
Joel Becker (56 yo)
Mr. Joel D. Becker serves as CEO & Director of at NeuroPace, Inc. since July 10, 2023 and serves as its President. He had been President of Cardiac Rhythm Management & Neuromodulation at Integer Holdings C...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.8yrs | US$3.02m | 0.026% $ 152.3k | |
| CFO and VP of Finance & Administration | 25yrs | US$1.09m | 0.24% $ 1.4m | |
| Chief Medical Officer | 20.8yrs | US$1.17m | 0.27% $ 1.5m | |
| Chief of Operations & Development | 1yr | no data | no data | |
| General Counsel & Corporate Secretary | 1.1yrs | no data | no data | |
| Vice President of Sales | 2yrs | no data | no data | |
| Vice President of Marketing | less than a year | no data | no data | |
| Vice President of Human Resources | less than a year | no data | no data |
Experienced Management: NPCE's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.8yrs | US$3.02m | 0.026% $ 152.3k | |
| Independent Director | 28.3yrs | US$122.16k | 1.11% $ 6.4m | |
| Chairman of the Board | 27.5yrs | US$172.16k | 1.79% $ 10.4m | |
| Independent Director | 2.3yrs | US$124.66k | 0.033% $ 192.6k | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 12.3yrs | US$134.66k | 0.13% $ 727.9k | |
| Board Observer | no data | no data | no data | |
| Independent Director | 3.5yrs | US$137.16k | 0% $ 0 | |
| Independent Director | 4.1yrs | US$137.16k | 0.043% $ 250.2k |
Experienced Board: NPCE's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/27 19:48 |
| End of Day Share Price | 2025/05/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NeuroPace, Inc. is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Ross Osborn | Cantor Fitzgerald & Co. |
| Rohin Patel | J.P. Morgan |